Abstract
Protein misfolding and aggregation into nano-scale ordered amyloid fibrils is one of the most exciting field of Biochemistry. The correct folding is essential for function of proteins and thus, existence of living systems. An effective protein quality control in living system recognizes and degrades misfolded protein quickly and prevents aggregation. Dysfunction or impaired function of this quality control system may result in deposition of protein aggregates. A number of diseases have been linked to deposition of insoluble amyloid aggregates in the brain or other organs. Recently, researchers have reported nano-based therapeutic options and early detection techniques for amyloid diseases. Moreover, thermodynamics of misfolding and aggregation has provided important clue for drug development. Researchers across the globe are working on the development of therapeutic strategies to combat protein aggregation diseases. In the current review, we aim to bring together recent developments about protein misfolding, aggregation and therapeutics against protein misfolding/ aggregation diseases.
Keywords: Protein folding, diseases, nano-fibrils
Current Proteomics
Title: Protein Nano-Fibrilar Structure and Associated Diseases
Volume: 7 Issue: 2
Author(s): Nandini Sarkar and Vikash Kumar Dubey
Affiliation:
Keywords: Protein folding, diseases, nano-fibrils
Abstract: Protein misfolding and aggregation into nano-scale ordered amyloid fibrils is one of the most exciting field of Biochemistry. The correct folding is essential for function of proteins and thus, existence of living systems. An effective protein quality control in living system recognizes and degrades misfolded protein quickly and prevents aggregation. Dysfunction or impaired function of this quality control system may result in deposition of protein aggregates. A number of diseases have been linked to deposition of insoluble amyloid aggregates in the brain or other organs. Recently, researchers have reported nano-based therapeutic options and early detection techniques for amyloid diseases. Moreover, thermodynamics of misfolding and aggregation has provided important clue for drug development. Researchers across the globe are working on the development of therapeutic strategies to combat protein aggregation diseases. In the current review, we aim to bring together recent developments about protein misfolding, aggregation and therapeutics against protein misfolding/ aggregation diseases.
Export Options
About this article
Cite this article as:
Sarkar Nandini and Kumar Dubey Vikash, Protein Nano-Fibrilar Structure and Associated Diseases, Current Proteomics 2010; 7 (2) . https://dx.doi.org/10.2174/157016410791330516
DOI https://dx.doi.org/10.2174/157016410791330516 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Serum Protein and Lipid Oxidation Marker Levels in Alzheimers Disease and Effects of Cholinesterase Inhibitors and Antipsychotic Drugs Therapy
Current Alzheimer Research Regulatory Cascade of Neuronal Loss and Glucose Metabolism
CNS & Neurological Disorders - Drug Targets Characterization of Serum Exosomes from a Transgenic Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Predicted fold for the ABri Amyloid Subunit: A Model for Amyloidogenesis in Familial British Dementia.
Protein & Peptide Letters Regulatory Triangle of Neurodegeneration, Adult Neurogenesis and MicroRNAs
CNS & Neurological Disorders - Drug Targets Subject Index To Volume 6
Central Nervous System Agents in Medicinal Chemistry Identification of Human ABAD Inhibitors for Rescuing Aβ-Mediated Mitochondrial Dysfunction
Current Alzheimer Research Vascular Risk Factors and Neurodegeneration in Ageing Related Dementias: Alzheimer’s Disease and Vascular Dementia
Current Alzheimer Research Cerebral Acetylcholinesterase Imaging: Development of the Radioprobes
Current Topics in Medicinal Chemistry GABAergic Functions and Depression: From Classical Therapies to Herbal Medicine
Current Drug Targets - CNS & Neurological Disorders Development of Radiotracers for the Determination of the Beta-Cell Mass In Vivo
Current Pharmaceutical Design Resurrecting Clinical Pharmacology As a Context for Alzheimer Disease Drug Development
Current Alzheimer Research GABAergic Modulation in Diabetic Encephalopathy-Related Depression
Current Pharmaceutical Design Alpha-7 Nicotinic Receptors in Nervous System Disorders: From Function to Therapeutic Perspectives
Central Nervous System Agents in Medicinal Chemistry Tauopathies – Focus on Changes at the Neurovascular Unit
Current Alzheimer Research Disrupting Self-Assembly and Toxicity of Amyloidogenic Protein Oligomers by “ Molecular Tweezers” - from the Test Tube to Animal Models
Current Pharmaceutical Design Molecular Pathways Involved in Apoptotic Cell Death in the Injured Cochlea: Cues to Novel Therapeutic Strategies
Current Pharmaceutical Design Dysregulated Pathway Identification of Alzheimer's Disease Based on Internal Correlation Analysis of Genes and Pathways
Combinatorial Chemistry & High Throughput Screening Serum Albumin Concentration and Cognitive Impairment
Current Alzheimer Research Structure and Ligand Based Rational Drug Design for Bace-1 Inhibitors
Current Bioactive Compounds